Marina Biotech, Inc. (MRNA) Reports Q3 Loss of $0.05

Marina Biotech, Inc. (NASDAQ: MRNA) reported Q3 EPS of ($0.05), versus ($0.39) reported last year. Revenue for the quarter came in at $286 thousand, versus $1.13 million reported last year.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Morgan Stanley Comments on Moderna (MRNA) Collaboration with OpenAI
• Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress
• Allison Transmission (ALSN) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY24 Revenue Guidance